3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Conditions
Leiomyoma
2
Hemorrhage
2
Sexual Infantilism
1
Polycystic Ovary Syndrome
1
Neoplasm Metastasis
1
Myoma
1
Myofibroma
1
Diabetes Insipidus
1
Craniopharyngioma
1
Blood Loss, Surgical
1
Adenomyosis
1
Interventions
telapristone acetate
18
ulipristal acetate
17
Uterine Myomectomy
13
vilaprisan
12
Leuprolide
11
relugolix
9
estradiol, norethindrone drug combination
9
asoprisnil
9
elagolix
7
Uterine Artery Embolization
7
Mifepristone
7
Estradiol
7
Bupivacaine
7
ulipristal
6
Tranexamic Acid
6
Saline Solution
5
Norethindrone Acetate
5
linzagolix
4
epigallocatechin gallate
4
Sodium Chloride
4
Letrozole
4
Hysterectomy
4
Vitamin B 6
3
Sugars
3
Misoprostol
3
Lidocaine
3
Gonadotropin-Releasing Hormone
3
Embolization, Therapeutic
3
cetrorelix
2
Vitamin D
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Leiomyoma
×
Oxytocin
×
Clear all
NCT04996498
2023-11-07
oxytocin
Ain Shams Maternity Hospital
Phase NA
Completed
60 enrolled
NCT03937401
2019-05-03
Oxytocin in MRI-HIFU
Turku University Hospital
Phase 4
Unknown
100 enrolled